Gender differences in antidepressant drug response

References

• Abernethy DR, Greenblatt DJ, Shader RI. Imipramine and desipramine disposition in the elderly. Journal of Pharmacology and Experimental Therapeutics 1985; 232: 183–188
   PubMed Web of Science ®Google Scholar
• Abumaria N, Rygula R, Hiemke C, Fuchs E, Havemann-Reinecke U, Ruther E, Flugge G. Effect of chronic citalopram on serotonin-related and stress-regulated genes in the dorsal raphe nucleus of the rat. European Neuropsychopharmacology 2007; 17: 417–429
   PubMed Web of Science ®Google Scholar
• Agosti V, Stewart JW. Atypical and non-atypical subtypes of depression: Comparison of social functioning, symptoms, course of illness, co-morbidity and demographic features. Journal of Affective Disorders 2001; 65: 75–79
   PubMed Web of Science ®Google Scholar
• K.J. Aitchison, & Gill, M. (2002). Pharmacogenetics in the Postgenomic Era. In R. Plomin, J. DeFries, I. Craig, & P. McGuffin (Eds.) Behavioral Genetics in the Postgenomic Era, pp. 235–361. Washington, D.C.: APA Books.
   Google Scholar
• Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. New England Journal of Medicine 2007; 356: 2684–2692
   PubMed Web of Science ®Google Scholar
• APA. Diagnostic and statistical manual of mental disorders – IV. American Psychiatric Press, Washington DC 2000
   Google Scholar
• Angst J, Dobler-Mikola A. Do the diagnostic criteria determine the sex ratio in depression?. Journal of Affective Disorders 1984; 7: 189–198
   PubMed Web of Science ®Google Scholar
• Angst J, Gamma A, Sellaro R, Zhang H, Merikangas K. Toward validation of atypical depression in the community: Results of the Zurich cohort study. Journal of Affective Disorders 2002; 72: 125–138
   PubMed Web of Science ®Google Scholar
• Angst J, Merikangas KR. Multi-dimensional criteria for the diagnosis of depression. Journal of Affective Disorders 2001; 62: 7–15
   PubMed Web of Science ®Google Scholar
• av-Citrin O, Shechtman S, Weinbaum D, Wajnberg R, Avgil M, Di GE, Ornoy A. Paroxetine and fluoxetine in pregnancy: A prospective, multicentre, controlled, observational study. British Journal of Clinical Pharmacology 2008; 66: 695–705
   PubMed Web of Science ®Google Scholar
• Baca E, Garcia-Garcia M, Porras-Chavarino A. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders. Progress in Neuropsychopharmacology and Biological Psychiatry 2004; 28: 57–65
   PubMed Web of Science ®Google Scholar
• Badawy AA, Evans M. Inhibition of rat liver tryptophan pyrrolase activity and elevation of brain tryptophan concentration by administration of antidepressants. Biochemical Pharmacology 1981; 30: 1211–1216
   PubMed Web of Science ®Google Scholar
• Baik SY, Jung KH, Choi MR, Yang BH, Kim SH, Lee JS, Chai YG. Fluoxetine-induced up-regulation of 14-3-3zeta and tryptophan hydroxylase levels in RBL-2H3 cells. Neuroscience Letters 2005; 374: 53–57
   PubMed Web of Science ®Google Scholar
• Baldwin DS, Anderson IM, Nutt DJ, Bandelow B, Bond A, Davidson JR, Wittchen HU. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: Recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 2005; 19: 567–596
   PubMed Web of Science ®Google Scholar
• Bano S, Akhter S, Afridi MI. Gender based response to fluoxetine hydrochloride medication in endogenous depression. Journal of the College of Physicians and Surgeons Pakistan 2004; 14: 161–165
   PubMedGoogle Scholar
• Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H, Koren G. Paroxetine and congenital malformations: Meta-analysis and consideration of potential confounding factors. Clinical Therapy 2007; 29: 918–926
   PubMed Web of Science ®Google Scholar
• Benazzi F. Prevalence and clinical features of atypical depression in depressed outpatients: A 467-case study. Psychiatry Research 1999; 86: 259–265
   PubMed Web of Science ®Google Scholar
• Benet LZ, Izumi T, Zhang Y, Silverman JA, Wacher VJ. Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery. Journal of Controlled Release 1999; 62: 25–31
   PubMed Web of Science ®Google Scholar
• Berard A, Ramos E, Rey E, Blais L, St-Andre M, Oraichi D. First trimester exposure to paroxetine and risk of cardiac malformations in infants: The importance of dosage. Birth Defects Research B Developmental and Reproductive Toxicology 2007; 80: 18–27
   PubMed Web of Science ®Google Scholar
• Berlanga C, Flores-Ramos M. Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine. Journal of Affective Disorders 2006; 95: 119–123
   PubMed Web of Science ®Google Scholar
• Berle JO, Steen VM, Aamo TO, Breilid H, Zahlsen K, Spigset O. Breastfeeding during maternal antidepressant treatment with serotonin reuptake inhibitors: Infant exposure, clinical symptoms, and cytochrome p450 genotypes. Journal of Clinical Psychiatry 2004; 65: 1228–1234
   PubMed Web of Science ®Google Scholar
• Biegon A, Reches A, Snyder L, McEwen BS. Serotonergic and noradrenergic receptors in the rat brain: Modulation by chronic exposure to ovarian hormones. Life Sciences 1983; 32: 2015–2021
   PubMed Web of Science ®Google Scholar
• Blier P, Bouchard C. Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs. British Journal of Pharmacology 1994; 113: 485–495
   PubMed Web of Science ®Google Scholar
• Breslau N, Schultz L, Peterson E. Sex differences in depression: A role for preexisting anxiety. Psychiatry Research 1995; 58: 1–12
   PubMed Web of Science ®Google Scholar
• Bukh JD, Bock C, Vinberg M, Gether U, Kessing LV. Gender differences among patients with a single depressive episode. Psychopathology 2010; 43: 159–169
   PubMed Web of Science ®Google Scholar
• Burke KC, Burke JD, Jr, Rae DS, Regier DA. Comparing age at onset of major depression and other psychiatric disorders by birth cohorts in five US community populations. Archives of General Psychiatry 1991; 48: 789–795
   PubMed Web of Science ®Google Scholar
• Chambers CD, Anderson PO, Thomas RG, Dick LM, Felix RJ, Johnson KA, Jones KL. Weight gain in infants breastfed by mothers who take fluoxetine. Pediatrics 1999; 104(5)e61–e65
   PubMed Web of Science ®Google Scholar
• Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. New England Journal of Medicine 2006; 354: 579–587
   PubMed Web of Science ®Google Scholar
• Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. Birth outcomes in pregnant women taking fluoxetine. New England Journal of Medicine 1996; 335: 1010–1015
   PubMed Web of Science ®Google Scholar
• Chaput Y, de Montigny C, Blier P. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat. Neuropsychopharmacology 1991; 5(4)219–229
   PubMed Web of Science ®Google Scholar
• Cheung C, Yu AM, Chen CS, Krausz KW, Byrd LG, Feigenbaum L, Gonzalez FJ. Growth hormone determines sexual dimorphism of hepatic cytochrome P450 3A4 expression in transgenic mice. Journal of Pharmacology and Experimental Therapeutics 2006; 316: 1328–1334
   PubMed Web of Science ®Google Scholar
• Cohen LS, Altshuler LL, Harlow BL, Nonacs R, Newport DJ, Viguera AC, Stowe ZN. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. Journal of the American Medical Association 2006; 295: 499–507
   PubMed Web of Science ®Google Scholar
• Cole JA, Ephross SA, Cosmatos IS, Walker AM. Paroxetine in the first trimester and the prevalence of congenital malformations. Pharmacoepidemiology and Drug Safety 2007; 16: 1075–1085
   PubMed Web of Science ®Google Scholar
• Cramer DW, Xu H. Predicting age at menopause. Maturitas 1996; 23: 319–326
   PubMed Web of Science ®Google Scholar
• Dahl ML, Bertilsson L, Nordin C. Steady-state plasma levels of nortriptyline and its 10-hydroxy metabolite: Relationship to the CYP2D6 genotype. Psychopharmacology (Berlin) 1996; 123: 315–319
   PubMed Web of Science ®Google Scholar
• Davidson JR, Meoni P, Haudiquet V, Cantillon M, Hackett D. Achieving remission with venlafaxine and fluoxetine in major depression: Its relationship to anxiety symptoms. Depression and Anxiety 2002; 16: 4–13
   PubMed Web of Science ®Google Scholar
• Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, Platt R. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiology and Drug Safety 2007; 16: 1086–1094
   PubMed Web of Science ®Google Scholar
• de Graaf R, Bijl RV, Smit F, Vollebergh WA, Spijker J. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: Findings from the Netherlands Mental Health Survey and Incidence Study. American Journal of Psychiatry 2002; 159(4)620–629
   PubMed Web of Science ®Google Scholar
• De Montigny C, Aghajanian GK. Tricyclic antidepressants: Long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science 1978; 202: 1303–1306
   PubMed Web of Science ®Google Scholar
• O. Diav-Citrin, Shechtman, S., Weinbaum, D., Wajnberg, R., Avgil, M., Di, G.E., … , Ornoy, A. (2008). Paroxetine and fluoxetine in pregnancy: A prospective, multicentre, controlled observational study. British Journal of Clinical Pharmacology, 66(5), 695–705.
   Google Scholar
• Donovan S, Clayton A, Beeharry M, Jones S, Kirk C, Waters K, Madeley R. Deliberate self-harm and antidepressant drugs. Investigation of a possible link. British Journal of Psychiatry 2000; 177: 551–556
   PubMed Web of Science ®Google Scholar
• Eberhard-Gran M, Eskild A, Opjordsmoen S. Use of psychotropic medications in treating mood disorders during lactation: Practical recommendations. CNS Drugs 2006; 20: 187–198
   PubMed Web of Science ®Google Scholar
• Einarson TR, Einarson A. Newer antidepressants in pregnancy and rates of major malformations: A meta-analysis of prospective comparative studies. Pharmacoepidemiology and Drug Safety 2005; 14: 823–827
   PubMed Web of Science ®Google Scholar
• Ejsing TB, Linnet K. Influence of P-glycoprotein inhibition on the distribution of the tricyclic antidepressant nortriptyline over the blood-brain barrier. Human Psychopharmacology 2005; 20: 149–153
   PubMed Web of Science ®Google Scholar
• Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, Trivedi MH. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report. American Journal of Psychiatry 2008; 165: 342–351
   PubMed Web of Science ®Google Scholar
• Fava M, Uebelacker LA, Alpert JE, Nierenberg AA, Pava JA, Rosenbaum JF. Major depressive subtypes and treatment response. Biological Psychiatry 1997; 42: 568–576
   PubMed Web of Science ®Google Scholar
• Fink G, Sumner B, Rosie R, Wilson H, McQueen J. Androgen actions on central serotonin neurotransmission: Relevance for mood, mental state and memory. Behavioural Brain Research 1999; 105: 53–68
   PubMed Web of Science ®Google Scholar
• Flint AJ, Rifat SL. Anxious depression in elderly patients. Response to antidepressant treatment. American Journal of Geriatric Psychiatry 1997; 5: 107–115
   PubMed Web of Science ®Google Scholar
• Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Archives of General Psychiatry 2004; 61: 62–70
   PubMed Web of Science ®Google Scholar
• Funck-Brentano C, Boelle PY, Verstuyft C, Bornert C, Becquemont L, Poirier JM. Measurement of CYP2D6 and CYP3A4 activity in vivo with dextromethorphan: Sources of variability and predictors of adverse effects in 419 healthy subjects. European Journal of Clinical Pharmacology 2005; 61: 821–829
   PubMed Web of Science ®Google Scholar
• Gex-Fabry M, Eap CB, Oneda B, Gervasoni N, Aubry JM, Bondolfi G, Bertschy G. CYP2D6 and ABCB1 genetic variability: Influence on paroxetine plasma level and therapeutic response. Therapeutic Drug Monitoring 2008; 30: 474–482
   PubMed Web of Science ®Google Scholar
• Glassman AH, Perel JM, Shostak M, Kantor SJ, Fleiss JL. Clinical implications of imipramine plasma levels for depressive illness. Archives of General Psychiatry 1977; 34: 197–204
   PubMed Web of Science ®Google Scholar
• Grace SL, Evindar A, Stewart DE. The effect of postpartum depression on child cognitive development and behavior: A review and critical analysis of the literature. Archives of Women's Mental Health 2003; 6: 263–274
   PubMedGoogle Scholar
• Granfors MT, Backman JT, Laitila J, Neuvonen PJ. Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2. Clinical Pharmacology and Therapeutics 2005; 78: 400–411
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, von Moltke LL. Gender has a small but statistically significant effect on clearance of CYP3A substrate drugs. Journal of Clinical Pharmacology 2008; 48: 1350–1355
   PubMed Web of Science ®Google Scholar
• Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996; 347: 930–933
   PubMed Web of Science ®Google Scholar
• Gundlah C, Alves SE, Clark JA, Pai LY, Schaeffer JM, Rohrer SP. Estrogen receptor-beta regulates tryptophan hydroxylase-1 expression in the murine midbrain raphe. Biological Psychiatry 2005; 57: 938–942
   PubMed Web of Science ®Google Scholar
• Gundlah C, Lu NZ, Bethea CL. Ovarian steroid regulation of monoamine oxidase-A and -B mRNAs in the macaque dorsal raphe and hypothalamic nuclei. Psychopharmacology (Berlin) 2002; 160: 271–282
   PubMed Web of Science ®Google Scholar
• Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: Meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. British Medical Journal 2005; 330: 385–390
   PubMed Web of Science ®Google Scholar
• Gupta B, Keers R, Uher R, McGuffin P, Aitchison KJ. Pharmacogenetics of antidepressant response. Depression: A translational approaches, C Pariante, R Nesse, D Nutt, L Wolpert. Oxford University Press, Oxford 2009; 299–314
   Google Scholar
• Hagg S, Spigset O, Dahlqvist R. Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers. British Journal of Clinical Pharmacology 2001; 51: 169–173
   PubMed Web of Science ®Google Scholar
• Hale TW, Shum S, Grossberg M. Fluoxetine toxicity in a breastfed infant. Clinical Pediatrics (Philadelphia) 2001; 40: 681–684
   PubMed Web of Science ®Google Scholar
• Hamilton J, Grant M, Jensvold M. Sex and treatment of depression. Psychopharmacology and women. Sex, gender and hormones, M Jensvold, U Halbreich, J Hamilton. American Psychiatric Association, Washington, DC 1996; 241–260
   Google Scholar
• Harris RZ, Benet LZ, Schwartz JB. Gender effects in pharmacokinetics and pharmacodynamics. Drugs 1995; 50: 222–239
   PubMed Web of Science ®Google Scholar
• Hawton K. Sex and suicide. Gender differences in suicidal behaviour. British Journal of Psychiatry 2000; 177: 484–485
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Ekblad U, Laine K. Transplacental transfer of amitriptyline and nortriptyline in isolated perfused human placenta. Psychopharmacology (Berlin) 2001; 153: 450–454
   PubMed Web of Science ®Google Scholar
• Hendrick V, Stowe ZN, Altshuler LL, Hwang S, Lee E, Haynes D. Placental passage of antidepressant medications. American Journal of Psychiatry 2003; 160: 993–996
   PubMed Web of Science ®Google Scholar
• Henkel V, Mergl R, Allgaier AK, Kohnen R, Moller HJ, Hegerl U. Treatment of depression with atypical features: A meta-analytic approach. Psychiatry Research 2006; 141: 89–101
   PubMed Web of Science ®Google Scholar
• Hildebrandt MG, Steyerberg EW, Stage KB, Passchier J, Kragh-Soerensen P. Are gender differences important for the clinical effects of antidepressants?. American Journal of Psychiatry 2003; 160: 1643–1650
   PubMed Web of Science ®Google Scholar
• Hiroi R, McDevitt RA, Neumaier JF. Estrogen selectively increases tryptophan hydroxylase-2 mRNA expression in distinct subregions of rat midbrain raphe nucleus: Association between gene expression and anxiety behavior in the open field. Biological Psychiatry 2006; 60: 288–295
   PubMed Web of Science ®Google Scholar
• Holloway MG, Laz EV, Waxman DJ. Codependence of growth hormone-responsive, sexually dimorphic hepatic gene expression on signal transducer and activator of transcription 5b and hepatic nuclear factor 4alpha. Molecular Endocrinology 2006; 20: 647–660
   PubMed Web of Science ®Google Scholar
• Hooper WD, Qing MS. The influence of age and gender on the stereoselective metabolism and pharmacokinetics of mephobarbital in humans. Clinical Pharmacology and Therapeutics 1990; 48: 633–640
   PubMed Web of Science ®Google Scholar
• Howell HB, Brawman-Mintzer O, Monnier J, Yonkers KA. Generalized anxiety disorder in women. Psychiatric Clinics of North America 2001; 24: 165–178
   PubMed Web of Science ®Google Scholar
• Huezo-Diaz P. Uher, R., Smith, R., Rietschel, M., Henigsberg, N., Marusic, A., … , McGuffin, P. 2009, Moderation of antidepressant response by the serotonin transporter gene in the GENDEP study. British Journal of Psychiatry, 195, 30–38
   Google Scholar
• Hunt CM, Westerkam WR, Stave GM. Effect of age and gender on the activity of human hepatic CYP3A. Biochemical Pharmacology 1992; 44: 275–283
   PubMed Web of Science ®Google Scholar
• M. Ingelman-Sundberg, Oscarson, M., Daly, A.K., Garte, S., & Nebert, D.W. (2001). Human cytochrome P-450 (CYP) genes: A web page for the nomenclature of alleles: http://www.cypalleles.ki.se. Cancer Epidemiology Biomarkers and Prevention, 10, 1307–1308.
   Google Scholar
• Janowsky DS, Davis JM. Progesterone-estrogen effects on uptake and release of norepinephrine by synaptosomes. Life Sciences 1970; 9: 525–531
   PubMed Web of Science ®Google Scholar
• Joyce PR, Mulder RT, Luty SE, Sullivan PF, McKenzie JM, Abbott RM, Stevens IF. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. Australia and New Zealand Journal of Psychiatry 2002; 36: 384–391
   PubMed Web of Science ®Google Scholar
• Kallen B, Olausson PO. Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn. Pharmacoepidemiology and Drug Safety 2008; 17: 801–806
   PubMed Web of Science ®Google Scholar
• Kashuba AD, Nafziger AN, Kearns GL, Leeder JS, Shirey CS, Gotschall R, Bertino JS, Jr. Quantification of intraindividual variability and the influence of menstrual cycle phase on CYP2D6 activity as measured by dextromethorphan phenotyping. Pharmacogenetics 1998; 8: 403–410
   PubMedGoogle Scholar
• Keers R, Uher, R., Mors, O., Hauser, J., Rietschel, J., Maier, W., … , Aitchison, K. (In preparation). The 5-HTTLPR interacts with stressful life events to predict response in GENDEP. Pharmacogenomics Journal
   Google Scholar
• Kemp J, Ilett KF, Booth J, Hackett LP. Excretion of doxepin and N-desmethyldoxepin in human milk. British Journal of Clinical Pharmacology 1985; 20: 497–499
   PubMed Web of Science ®Google Scholar
• Khan A, Brodhead AE, Schwartz KA, Kolts RL, Brown WA. Sex differences in antidepressant response in recent antidepressant clinical trials. Journal of Clinical Psychopharmacology 2005; 25: 318–324
   PubMed Web of Science ®Google Scholar
• Khan A, Schwartz KA, Kolts RL, Brown WA. BMI, sex, and antidepressant response. Journal of Affective Disorders 2007; 99: 101–106
   PubMed Web of Science ®Google Scholar
• Kim SW, Park SY, Hwang O. Up-regulation of tryptophan hydroxylase expression and serotonin synthesis by sertraline. Molecular Pharmacology 2002; 61: 778–785
   PubMed Web of Science ®Google Scholar
• Kloiber S, Ising M, Reppermund S, Horstmann S, Dose T, Majer M, Lucae S. Overweight and obesity affect treatment response in major depression. Biological Psychiatry 2007; 62: 321–326
   PubMed Web of Science ®Google Scholar
• Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Keller MB. Gender differences in treatment response to sertraline versus imipramine in chronic depression. American Journal of Psychiatry 2000; 157: 1445–1452
   PubMed Web of Science ®Google Scholar
• Kreiss DS, Lucki I. Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei. Journal of Pharmacology and Experimental Therapeutics 1994; 269: 1268–1279
   PubMed Web of Science ®Google Scholar
• Labbe L, Sirois C, Pilote S, Arseneault M, Robitaille NM, Turgeon J, Hamelin BA. Effect of gender, sex hormones, time variables and physiological urinary pH on apparent CYP2D6 activity as assessed by metabolic ratios of marker substrates. Pharmacogenetics 2000; 10: 425–438
   PubMedGoogle Scholar
• Laine K, Kytola J, Bertilsson L. Severe adverse effects in a newborn with two defective CYP2D6 alleles after exposure to paroxetine during late pregnancy. Therapeutic Drug Monitoring 2004; 26: 685–687
   PubMed Web of Science ®Google Scholar
• Laine K, Tybring G, Bertilsson L. No sex-related differences but significant inhibition by oral contraceptives of CYP2C19 activity as measured by the probe drugs mephenytoin and omeprazole in healthy Swedish white subjects. Clinical Pharmacology and Therapeutics 2000; 68: 151–159
   PubMed Web of Science ®Google Scholar
• Lester BM, Cucca J, Andreozzi L, Flanagan P, Oh W. Possible association between fluoxetine hydrochloride and colic in an infant. Journal of the American Academy of Child and Adolescent Psychiatry 1993; 32: 1253–1255
   PubMed Web of Science ®Google Scholar
• Li D, Liu L, Odouli R. Presence of depressive symptoms during early pregnancy and the risk of preterm delivery: A prospective cohort study. Human Reproduction 2009; 24: 146–153
   PubMed Web of Science ®Google Scholar
• Loughhead AM, Fisher AD, Newport DJ, Ritchie JC, Owens MJ, De Vane CL, Stowe ZN. Antidepressants in amniotic fluid: Another route of fetal exposure. American Journal of Psychiatry 2006a; 163: 145–147
   PubMed Web of Science ®Google Scholar
• Loughhead AM, Stowe ZN, Newport DJ, Ritchie JC, De Vane CL, Owens MJ. Placental passage of tricyclic antidepressants. Biological Psychiatry 2006b; 59: 287–290
   PubMed Web of Science ®Google Scholar
• Louik C, Lin AE, Werler MM, Hernandez-Diaz S, Mitchell AA. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. New England Journal of Medicine 2007; 356: 2675–2683
   PubMed Web of Science ®Google Scholar
• Lu NZ, Eshleman AJ, Janowsky A, Bethea CL. Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution, and function in female macaques. Molecular Psychiatry 2003; 8: 353–360
   PubMed Web of Science ®Google Scholar
• Luine VN, Khylchevskaya RI, McEwen BS. Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain. Brain Research 1975; 86: 293–306
   PubMed Web of Science ®Google Scholar
• Marcus SM, Flynn HA, Blow FC, Barry KL. Depressive symptoms among pregnant women screened in obstetrics settings. Journal of Women's Health 2003; 12: 373–380
   PubMed Web of Science ®Google Scholar
• Marcus SM, Young EA, Kerber KB, Kornstein S, Farabaugh AH, Mitchell J, Rush AJ. Gender differences in depression: Findings from the STAR*D study. Journal of Affective Disorders 2005; 87: 141–150
   PubMed Web of Science ®Google Scholar
• Martenyi F, Dossenbach M, Mraz K, Metcalfe S. Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: A double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile. European Neuropsychopharmacology 2001; 11: 227–232
   PubMed Web of Science ®Google Scholar
• Matheson I, Pande H, Alertsen AR. Respiratory depression caused by N-desmethyldoxepin in breast milk. Lancet 1985; 2: 1124
   PubMed Web of Science ®Google Scholar
• Matza LS, Revicki DA, Davidson JR, Stewart JW. Depression with atypical features in the National Comorbidity Survey: Classification, description, and consequences. Archives of General Psychiatry 2003; 60: 817–826
   PubMed Web of Science ®Google Scholar
• Merlob P, Birk E, Sirota L, Linder N, Berant M, Stahl B, Klinger G. Are selective serotonin reuptake inhibitors cardiac teratogens? Echocardiographic screening of newborns with persistent heart murmur. Birth Defects Research A: Clinical Molecular Teratology 2009; 85: 837–841
   PubMed Web of Science ®Google Scholar
• Moody JP, Tait AC, Todrick A. Plasma levels of imipramine and desmethylimipramine during therapy. British Journal of Psychiatry 1967; 113: 183–193
   PubMed Web of Science ®Google Scholar
• Morgan ML, Cook IA, Rapkin AJ, Leuchter AF. Estrogen augmentation of antidepressants in perimenopausal depression: A pilot study. Journal of Clinical Psychiatry 2005; 66: 774–780
   PubMed Web of Science ®Google Scholar
• Morissette M, Levesque D, Belanger A, Di PT. A physiological dose of estradiol with progesterone affects striatum biogenic amines. Canadian Journal of Physiology and Pharmacology 1990; 68: 1520–1526
   PubMed Web of Science ®Google Scholar
• Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: Literature review and implications for clinical applications. Journal of the American Medical Association 2005; 293: 2372–2383
   PubMed Web of Science ®Google Scholar
• Mrazek DA. Rush, A.J., Biernacka, J.M., O'Kane, D.J., Cunningham, J.M., Wieben, E.D., … Weinshilboum, R.M. 2008, SLC6A4 variation and citalopram response. American Journal of Medical Genetics B: Neuropsychiatric Genetics, 150 B, 341–351
   Google Scholar
• Nagata H, Nozaki M, Nakano H. Short-term combinational therapy of low-dose estrogen with selective serotonin re-uptake inhibitor (fluvoxamine) for oophorectomized women with hot flashes and depressive tendencies. Journal of Obstetric and Gynaecological Research 2005; 31: 107–114
   PubMed Web of Science ®Google Scholar
• Nelson JC. Anxious depression and response to treatment. American Journal of Psychiatry 2008; 165: 297–299
   PubMed Web of Science ®Google Scholar
• Neumeister A. Tryptophan depletion, serotonin, and depression: Where do we stand?. Psychopharmacology Bulletin 2003; 37: 99–115
   PubMedGoogle Scholar
• Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzengeza S, de Montigny C, Diksic M. Differences between males and females in rates of serotonin synthesis in human brain. Proceedings of the National Academy of Sciences of the USA 1997; 94(10)5308–5313
   PubMed Web of Science ®Google Scholar
• Niznik HB, Tyndale RF, Sallee FR, Gonzalez FJ, Hardwick JP, Inaba T, Kalow W. The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: Resolution and identification of two distinct [3H]GBR-12935 binding proteins. Archives of Biochemistry and Biophysics 1990; 276: 424–432
   PubMed Web of Science ®Google Scholar
• Novick JS, Stewart JW, Wisniewski SR, Cook IA, Manev R, Nierenberg AA, Rush AJ. Clinical and demographic features of atypical depression in outpatients with major depressive disorder: Preliminary findings from STAR*D. Journal of Clinical Psychiatry 2005; 66: 1002–1011
   PubMed Web of Science ®Google Scholar
• Nulman I, Rovet J, Stewart DE, Wolpin J, Pace-Asciak P, Shuhaiber S, Koren G. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: A prospective, controlled study. American Journal of Psychiatry 2002; 159: 1889–1895
   PubMed Web of Science ®Google Scholar
• Oberlander TF, Bonaguro RJ, Misri S, Papsdorf M, Ross CJ, Simpson EM. Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications. Molecular Psychiatry 2008; 13: 65–73
   PubMed Web of Science ®Google Scholar
• Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Archives of General Psychiatry 2006; 63: 898–906
   PubMed Web of Science ®Google Scholar
• Osterlund MK, Halldin C, Hurd YL. Effects of chronic 17beta-estradiol treatment on the serotonin 5-HT(1A) receptor mRNA and binding levels in the rat brain. Synapse 2000; 35: 39–44
   PubMed Web of Science ®Google Scholar
• Osterlund MK, Hurd YL. Acute 17 beta-estradiol treatment down-regulates serotonin 5HT1A receptor mRNA expression in the limbic system of female rats. Brain Research: Molecular Brain Research 1998; 55: 169–172
   PubMedGoogle Scholar
• Ou-Yang DS, Huang SL, Wang W, Xie HG, Xu ZH, Shu Y, Zhou HH. Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population. British Journal of Clinical Pharmacology 2000; 49: 145–151
   PubMed Web of Science ®Google Scholar
• Pae CU, Mandelli L, Kim TS, Han C, Masand PS, Marks DM, Serretti A. Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: A pilot study on differential effects of sex hormones on antidepressant effects. Biomedicine and Pharmacotherapy 2009; 63: 228–235
   PubMed Web of Science ®Google Scholar
• Papakostas GI, Petersen T, Iosifescu DV, Burns AM, Nierenberg AA, Alpert JE, Fava M. Obesity among outpatients with major depressive disorder. International Journal of Neuropsychopharmacology 2005; 8: 59–63
   PubMed Web of Science ®Google Scholar
• Parker G, Parker K, Austin MP, Mitchell P, Brotchie H. Gender differences in response to differing antidepressant drug classes: Two negative studies. Psychological Medicine 2003; 33: 1473–1477
   PubMed Web of Science ®Google Scholar
• Paykel ES, Rowan PR, Parker RR, Bhat AV. Response to phenelzine and amitriptyline in subtypes of outpatient depression. Archives of General Psychiatry 1982; 39: 1041–1049
   PubMed Web of Science ®Google Scholar
• Payne JL. Antidepressant use in the postpartum period: Practical considerations. American Journal of Psychiatry 2007; 164: 1329–1332
   PubMed Web of Science ®Google Scholar
• Pecins-Thompson M, Brown NA, Kohama SG, Bethea CL. Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques. Journal of Neuroscience 1996; 16: 7021–7029
   PubMed Web of Science ®Google Scholar
• Perroud N, Uher R, Marusic A, Rietschel M, Mors O, Henigsberg N, Aitchison KJ. Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): A clinical trial. British Medical Council: Medicine 2009; 7: 60–74
   Google Scholar
• Pfuhlmann B, Gerlach M, Burger R, Gonska S, Unterecker S, Jabs B, Deckert J. Therapeutic drug monitoring of tricyclic antidepressants in everyday clinical practice. Journal of Neural Transmission 2007; 72: S287–296
   Google Scholar
• Pineyro G, Blier P. Autoregulation of serotonin neurons: Role in antidepressant drug action. Pharmacology Review 1999; 51: 533–591
   PubMed Web of Science ®Google Scholar
• Pollock BG. Gender differences in psychotropic drug metabolism. Psychopharmacology Bulletin 1997; 33: 235–241
   PubMed Web of Science ®Google Scholar
• Pollock BG, Ferrell RE, Mulsant BH, Mazumdar S, Miller M, Sweet RA, Kupfer DJ. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology 2000; 23: 587–590
   PubMed Web of Science ®Google Scholar
• Pollock BG, Wylie M, Stack JA, Sorisio DA, Thompson DS, Kirshner MA, Condifer KA. Inhibition of caffeine metabolism by estrogen replacement therapy in postmenopausal women. Journal of Clinical Pharmacology 1999; 39: 936–940
   PubMed Web of Science ®Google Scholar
• Posternak MA, Zimmerman M. Symptoms of atypical depression. Psychiatry Research 2001; 104: 175–181
   PubMed Web of Science ®Google Scholar
• Preskorn SH, Mac DS. Plasma levels of amitriptyline: Effect of age and sex. Journal of Clinical Psychiatry 1985; 46: 276–277
   PubMed Web of Science ®Google Scholar
• Quitkin FM, Stewart JW, McGrath PJ. Gender differences in treatment response. American Journal of Psychiatry 2001; 158: 1531–1533
   PubMed Web of Science ®Google Scholar
• Quitkin FM, Stewart JW, McGrath PJ, Taylor BP, Tisminetzky MS, Petkova E, Klein DF. Are there differences between women's and men's antidepressant responses?. American Journal of Psychiatry 2002; 159: 1848–1854
   PubMed Web of Science ®Google Scholar
• Rampono J, Hackett LP, Kristensen JH, Kohan R, Page-Sharp M, Ilett KF. Transfer of escitalopram and its metabolite demethylescitalopram into breastmilk. British Journal of Clinical Pharmacology 2006; 62: 316–322
   PubMed Web of Science ®Google Scholar
• Rapkin AJ, Mikacich JA, Moatakef-Imani B, Rasgon N. The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders. Current Psychiatry Reports 2002; 4: 419–428
   PubMedGoogle Scholar
• Raskin A. Age-sex differences in response to antidepressant drugs. Journal of Nervous Mental Disorders 1974; 159: 120–130
   PubMed Web of Science ®Google Scholar
• Rasmussen BB, Brosen K. Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors?. Therapeutic Drug Monitoring 2000; 22: 143–154
   PubMed Web of Science ®Google Scholar
• Rausch JL, Johnson ME, Kasik KE, Stahl SM. Temperature regulation in depression: Functional 5HT1A receptor adaptation differentiates antidepressant response. Neuropsychopharmacology 2006; 31: 2274–2280
   PubMed Web of Science ®Google Scholar
• Reis M, Kallen B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: An update using Swedish data. Psychological Medicine 2010; Jan 5: 1–11
   Google Scholar
• Reis M, Lundmark J, Bengtsson F. Therapeutic drug monitoring of racemic citalopram: A 5-year experience in Sweden, 1992–1997. Therapeutic Drug Monitoring 2003; 25: 183–191
   PubMed Web of Science ®Google Scholar
• Relling MV, Lin JS, Ayers GD, Evans WE. Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities. Clinical Pharmacology and Therapeutics 1992; 52: 643–658
   PubMed Web of Science ®Google Scholar
• Riad M, Zimmer L, Rbah L, Watkins KC, Hamon M, Descarries L. Acute treatment with the antidepressant fluoxetine internalizes 5-HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F]MPPF in the nucleus raphe dorsalis of rat. Journal of Neuroscience 2004; 24: 5420–5426
   PubMed Web of Science ®Google Scholar
• Ronfeld RA, Tremaine LM, Wilner KD. Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers. Clinical Pharmacokinetics 1997; 32: S22–30
   PubMed Web of Science ®Google Scholar
• Rossi DV, Valdez M, Gould GG, Hensler JG. Chronic administration of venlafaxine fails to attenuate 5-HT1A receptor function at the level of receptor-G protein interaction. International Journal of Neuropsychopharmacology 2006; 9: 393–406
   PubMed Web of Science ®Google Scholar
• Samsonova ML, Lapin IP. Antidepressants and liver tryptophan pyrrolase activity. Biochemical Pharmacology 1973; 22: 1499–1507
   PubMed Web of Science ®Google Scholar
• Savitz J, Lucki I, Drevets WC. 5-HT(1A) receptor function in major depressive disorder. Progress in Neurobiology 2009; 88: 17–31
   PubMed Web of Science ®Google Scholar
• Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, Rubinow DR. Estrogen replacement in perimenopause-related depression: A preliminary report. American Journal of Obstetrics and Gynecology 2000; 183: 414–420
   PubMed Web of Science ®Google Scholar
• Schmidt R, Baumann F, Hanschmann H, Geissler F, Preiss R. Gender difference in ifosfamide metabolism by human liver microsomes. European Journal of Drug Metabolism and Pharmacokinetics 2001; 26: 193–200
   PubMed Web of Science ®Google Scholar
• Schneid-Kofman N, Sheiner E, Levy A. Psychiatric illness and adverse pregnancy outcome. International Journal of Gynaecology and Obstetrics 2008; 101: 53–56
   PubMed Web of Science ®Google Scholar
• Schneider LS, Small GW, Clary CM. Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. American Journal of Geriatric Psychiatry 2001; 9: 393–399
   PubMed Web of Science ®Google Scholar
• Schneider LS, Small GW, Hamilton SH, Bystritsky A, Nemeroff CB, Meyers BS. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. American Journal of Geriatric Psychiatry 1997; 5: 97–106
   PubMed Web of Science ®Google Scholar
• Schuetz EG, Furuya KN, Schuetz JD. Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. Journal of Pharmacology and Experimental Therapeutics 1995; 275: 1011–1018
   PubMed Web of Science ®Google Scholar
• Serretti A, Kato M, de Ronchi D, Kinoshita T. Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Molecular Psychiatry 2007; 12: 247–257
   PubMed Web of Science ®Google Scholar
• Sharp T, Boothman L, Raley J, Queree P. Important messages in the ‘post’: Recent discoveries in 5-HT neurone feedback control. Trends in Pharmacological Science 2007; 28: 629–636
   PubMed Web of Science ®Google Scholar
• Souery D, Oswald P, Massat I, Bailer U, Bollen J, Demyttenaere K, Kasper S, Mendlewicz J. Clinical factors associated with treatment resistance in major depressive disorder: Results from a European multicenter study. Journal of Clinical Psychiatry 2007; 68: 1062–1070
   PubMed Web of Science ®Google Scholar
• Spencer MJ. Fluoxetine hydrochloride (Prozac) toxicity in a neonate. Pediatrics 1993; 92: 721–722
   PubMed Web of Science ®Google Scholar
• Stewart JW, McGrath PJ, Quitkin FM. Do age of onset and course of illness predict different treatment outcome among DSM IV depressive disorders with atypical features?. Neuropsychopharmacology 2002; 26: 237–245
   PubMed Web of Science ®Google Scholar
• Stowe ZN, Hostetter AL, Newport DJ. The onset of postpartum depression: Implications for clinical screening in obstetrical and primary care. American Journal of Obstetrics and Gynecology 2005; 192: 522–526
   PubMed Web of Science ®Google Scholar
• Tamminga WJ, Wemer J, Oosterhuis B, Weiling J, Wilffert B, de Leij LF, Jonkman JH. CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: Indications for oral contraceptive-related gender differences. European Journal of Clinical Pharmacology 1999; 55: 177–184
   PubMed Web of Science ®Google Scholar
• Tantcheva-Poor I, Zaigler M, Rietbrock S, Fuhr U. Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. Pharmacogenetics 1999; 9: 131–144
   PubMedGoogle Scholar
• Thase ME, Frank E, Kornstein SG, Yonkers KA. Gender differences in response to treatments of depression. Gender and its effects on psychopathology, E Frank. American Psychiatric Press, Washington DC 2000; 103–129
   Google Scholar
• Thase ME, Reynolds III CF, Frank E, Simons AD, McGeary J, Fasiczka AL, Garamoni GG, Kupfer DJ. Do depressed men and women respond similarly to cognitive behavior therapy?. American Journal of Psychiatry 1994; 151: 500–505
   PubMed Web of Science ®Google Scholar
• Thase ME, Trivedi MH, Rush AJ. MAOIs in the contemporary treatment of depression. Neuropsychopharmacology 1995; 12: 185–219
   PubMed Web of Science ®Google Scholar
• Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Fava M. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. American Journal of Psychiatry 2006; 163: 28–40
   PubMed Web of Science ®Google Scholar
• Uher R, Maier W, Hauser J, Marusic A, Schmael C, Mors O, McGuffin P. Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. British Journal of Psychiatry 2009a; 194: 252–259
   PubMed Web of Science ®Google Scholar
• Uher R, Mors O, Hauser J, Rietschel M, Maier W, Kozel D, Farmer A. Body weight as a predictor of antidepressant efficacy in the GENDEP project. Journal of Affective Disorders 2009b; 118: 147–154
   PubMed Web of Science ®Google Scholar
• Uhr M, Grauer MT, Holsboer F. Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption. Biological Psychiatry 2003; 54: 840–846
   PubMed Web of Science ®Google Scholar
• Ulrich S, Lauter J. Comprehensive survey of the relationship between serum concentration and therapeutic effect of amitriptyline in depression. Clinical Pharmacokinetics 2002; 41: 853–876
   PubMed Web of Science ®Google Scholar
• Vitale ML, Chiocchio SR. Serotonin, a neurotransmitter involved in the regulation of luteinizing hormone release. Endocrine Review 1993; 14: 480–493
   PubMed Web of Science ®Google Scholar
• Warrington SJ. Clinical implications of the pharmacology of sertraline. International Clinical Psychopharmacology 1991; 6: S11–21
   PubMed Web of Science ®Google Scholar
• Watkins PB. Drug metabolism by cytochromes P450 in the liver and small bowel. Gastroenterology Clinics of North America 1992; 21: 511–526
   PubMed Web of Science ®Google Scholar
• Weissman AM, Levy BT, Hartz AJ, Bentler S, Donohue M, Ellingrod VL, Wisner KL. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. American Journal of Psychiatry 2004; 161: 1066–1078
   PubMed Web of Science ®Google Scholar
• Wogelius P, Norgaard M, Gislum M, Pedersen L, Munk E, Mortensen PB, Sorensen HT. Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations. Epidemiology 2006; 17: 701–704
   PubMed Web of Science ®Google Scholar
• Wolbold R, Klein K, Burk O, Nussler AK, Neuhaus P, Eichelbaum M, Zanger UM. Sex is a major determinant of CYP3A4 expression in human liver. Hepatology 2003; 38: 978–988
   PubMed Web of Science ®Google Scholar
• Yonkers KA, Warshaw MG, Massion AO, Keller MB. Phenomenology and course of generalised anxiety disorder. British Journal of Psychiatry 1996; 168: 308–313
   PubMed Web of Science ®Google Scholar
• Young E, Korszun A. Sex, trauma, stress hormones and depression. Molecular Psychiatry 2010; 15: 23–28
   PubMed Web of Science ®Google Scholar
• Zanardi R, Rossini D, Magri L, Malaguti A, Colombo C, Smeraldi E. Response to SSRIs and role of the hormonal therapy in post-menopausal depression. European Neuropsychopharmacology 2007; 17: 400–405
   PubMed Web of Science ®Google Scholar
• Zohar J, Westenberg HG. Anxiety disorders: A review of tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatrica Scandinavica 2000; 403: S39–49
   Google Scholar